Proton pump inhibitors should not be used to treat persistent throat symptomsBMJ 2022; 376 doi: https://doi.org/10.1136/bmj.o652 (Published 17 March 2022) Cite this as: BMJ 2022;376:o652
- Helen Saul, editor in chief1,
- Deniz Gursul, research dissemination officer1,
- Jemma Kwint, senior research fellow1 ,
- James O’Hara, clinical senior lecturer, honorary consultant, ear, nose, and throat surgeon23
- 1NIHR Centre for Engagement and Dissemination, Twickenham, UK
- 2Newcastle University, Newcastle upon Tyne, UK
- 3Newcastle upon Tyne Hospitals NHS Foundation Trust
- Correspondence to H Saul
Wilson JA, Stocken DD, Watson GC, et al. Lansoprazole for persistent throat symptoms in secondary care: the TOPPITS RCT. Health Technol Assess 2021;25:1-118.
To read the full NIHR Alert, go to: https://evidence.nihr.ac.uk/alert/throat-symptoms-should-not-be-treated-with-ppis/
Competing interests: The BMJ has judged that there are no disqualifying financial ties to commercial companies. The authors declare the following other interests: none.
Further details of The BMJ policy on financial interests are here: https://www.bmj.com/about-bmj/resources-authors/forms-policies-and-checklists/declaration-competing-interests
All authors contributed to the development and review of this summary, as part of the wider NIHR Alerts editorial team.
More summaries of NIHR research are available at https://evidence.nihr.ac.uk/alerts/
Disclaimer: NIHR Alerts are owned by the Department of Health and Social Care and are made available to The BMJ under licence. NIHR Alerts report and comment on health and social care research but do not offer any endorsement of the research. The NIHR assumes no responsibility or liability arising from any error or omission or from the use of any information contained in NIHR Alerts.
Permission to reuse these articles should be directed to NIHRAlerts@nihr.ac.uk